Arkolith/Insider Trading/ALZN/Form 4

Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Jul 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$204K
Net Open-Market Flow
-$204K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 24, 2025Sell(S)10K$2.93$28K83K
Jul 23, 2025Sell(S)60K$2.95$176K92K
Jul 23, 2025Conversion(C)143K$2.32$333K152K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 23, 2025Conversion(C)333$1000.00$333K2K

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-010933) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML